WASHINGTON, Aug. 13 -- The Senate Finance Subcommittee on Health Care released the following written testimony by Kevin Outterson, law professor and executive director of combating antibiotic-resistant bacteria biopharmaceutical accelerator at Boston University, from an Aug. 4, 2026, hearing entitled "Building a Resilient Health Care Future with Biotechnology": * * * Superbugs have long been the enemies of civilization. From the Black Death in the Middle Ages (plague bacteria), to the recognition that cholera was caused by something in the wa more PR

WASHINGTON, Aug. 13 -- The Senate Finance Subcommittee on Health Care released the following written testimony by Vera P. Luther, section chief of infectious diseases and international health at Dartmouth Health, New Hampshire, and a fellow of the Infectious Diseases Society of America, from an Aug. 4, 2026, hearing entitled "Building a Resilient Health Care Future with Biotechnology": * * * Chairman Young, Ranking Member Hassan, and distinguished members of the Subcommittee, thank you for holding today's hearing and for the opportunity to te more PR

WASHINGTON, Aug. 13 -- The Senate Finance Subcommittee on Health Care released the following written testimony by Alan D. Palkowitz, president and CEO of the Indiana Biosciences Research Institute, Indianapolis, from an Aug. 4, 2026, hearing entitled "Building a Resilient Health Care Future with Biotechnology": * * * America remains the world's leader in biomedical discovery. Our universities, academic medical centers, biotechnology companies, pharmaceutical industry, nonprofit research organizations, entrepreneurs, investors, and federal res more PR

WASHINGTON, Aug. 13 -- The Senate Finance Subcommittee on Health Care released the following written testimony by Michelle Rozo, vice chair of the National Security Commission on Emerging Biotechnology, from an Aug. 4, 2026, hearing entitled "Building a Resilient Health Care Future with Biotechnology": * * * Chairman Young, Ranking Member Hassan, and members of the Subcommittee, thank you for the opportunity to testify. It is an honor to appear before you on behalf of the National Security Commission on Emerging Biotechnology to discuss why b more PR

WASHINGTON, Aug. 13 -- The House Science, Space and Technology Committee released the following testimony by Michael J.K. Kratsios, director of the White House Office of Science and Technology Policy, from a July 22, 2026, hearing entitled "Unleashing the Golden Age of Science: Examining the Priorities of the FY2027 Research and Technology Enterprise": * * * Thank you, Chairman Babin, and Ranking Member Lofgren, for inviting me to speak to you today about the nation's science and technology enterprise and this administration's priorities. In more PR